As a pharmaceutical company run by U.S. Sen. Joe Manchin's daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum.
Dr. James Baker, Food Allergy Research and Education CEO, discusses the controversy surrounding Mylan's EpiPen price surge and what the organization is doing to advocate for its members who need the life-saving drug.
Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.
Pharmaceutical company AstraZeneca plans to sell its antibiotic pills business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included.
Ford is recalling more than 88,000 cars and SUVs in North America because the engines can stall without warning due to a fuel pump problem.
Mylan Labs, the Pittsburgh-based pharmaceutical giant at the center of a major drug pricing storm over the EpiPen, managed to pull off a tax-ducking corporate inversion just a year and a half ago.
New research from Glassdoor, a website where employees can anonymously review their companies, shows that employees define what makes a great CEO based on multiple factors.
Pharmaceutical company AstraZeneca plans to sell its molecule antibiotics business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included.
Pharmaceutical company AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer in a deal that could be valued at more than $1.5 billion.
On a seaside field south of Shanghai, workers are constructing a nuclear reactor that is the flagship for Beijing's ambition to compete with the United States, France and Russia as an exporter of atomic power technology.
Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.
Outrage over Mylan Pharmaceuticals’ price hikes on EpiPens has the ‘Erin Brockovich’ of food calling for a congressional investigation.
Robyn OBrien, Allergy Kids Foundation founder, discusses the growing number of kids with food allergies and why she is concerned about the 400% price increase in Mylan's EpiPen.
The EpiPen price hike rolled out by Mylan Labs is causing outrage and one concerned mother is doing something about it.
McDonald's is recalling millions fitness bands that had been given away in Happy Meals because they might cause skin irritation or burns to children.
Two senior lawmakers on the U.S. Senate's Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions.
Stocks are moderately lower in midday trading Monday as the market drifts between small gains and losses.
Valeant Pharmaceuticals replaced Robert Rosiello as chief financial officer as the embattled company attempts to normalize operations amid a host of ongoing investigations and class action lawsuits.
Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.
Pfizer will pay $81.50 a share, a 21% premium to Medivation's closing stock price Friday. Medivation shares traded up 20% to $80.47 in early trading as Pfizer shares fell 5 cents to $34.92.